Enanta Pharmaceuticals, Inc. ENTA

Set alert

Price alert · ENTA

All alert types
10.43 USD -0.28 -2.61%

At close · Nov 2

10.43 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
10.37 × 2
Ask
10.43 × 2
10.15 Day range 10.86
10.14 52-week range 17.15
YTD
-33.86%
1 year
-4.84%
Open
10.74
Prev close
10.71
Mkt cap
303.78M
Vol
350.52K
Avg vol
251.47K
EPS
-2.42
P/E
0.00
Div yield
0.00%
More statistics
Low
10.15
High
10.86
Forward P/E
-1.32
Beta
0.57
Short ratio
20.91
Inst. own
100.66%
Dividend
0.00
Ex-div date
Earnings
Feb 5, 2025
50-d avg
9.78
200-d avg
12.44
1y target
16.88

5D chart

Chart tools
Interval

Signals (95)
NameTimeAgo
SMA: BearishOct 30, 3:55 PM3 days ago
MACD: Sell SignalOct 30, 3:55 PM3 days ago
SMA: BullishOct 30, 3:50 PM3 days ago
MACD: Buy SignalOct 30, 3:50 PM3 days ago
MACD: Sell SignalOct 30, 3:30 PM3 days ago
SMA: BearishOct 30, 3:05 PM3 days ago
SMA: BullishOct 30, 3:00 PM3 days ago
MACD: Buy SignalOct 30, 3:00 PM3 days ago
MACD: Sell SignalOct 30, 2:30 PM3 days ago
MACD: Buy SignalOct 30, 2:25 PM3 days ago
MACD: Sell SignalOct 30, 1:15 PM3 days ago
SMA: BearishOct 30, 1:10 PM3 days ago
MACD: Buy SignalOct 30, 12:50 PM3 days ago
MACD: Sell SignalOct 30, 12:00 PM3 days ago
MACD: Buy SignalOct 30, 11:55 AM3 days ago
MACD: Sell SignalOct 30, 11:50 AM3 days ago
SMA: BearishOct 30, 11:40 AM3 days ago
SMA: BullishOct 30, 10:50 AM3 days ago
MACD: Buy SignalOct 30, 10:50 AM3 days ago
SMA: BullishOct 30, 10:40 AM3 days ago

Newest 20 of 95.

Analyst view

Consensus: buy

Buy
Price target (mean) 16.88 +61.8% upside
Target (low)
9.00
Target (mean)
16.88
Target (high)
27.00
Ratings (0m) 8 4 buy · 3 hold · 1 sell
  • Strong buy2
  • Buy2
  • Hold3
  • Sell0
  • Strong sell1

Recommendation trend

  • This month 8
  • 1 month ago 8
  • 2 months ago 8
  • 3 months ago 8

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

ENTA analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-1.27-1.38 – -1.16-1.58+19.8%17.67M-1.9%4
Next quarter-1.41-1.45 – -1.32-1.47+4.4%16.42M-3.7%4
Current year-5.11-5.67 – -4.70-5.48+6.7%72.47M+7.1%4
Next year-5.25-8.67 – -2.95-5.11-2.7%69.79M-3.7%3

Upgrades and downgrades

The latest rating changes

ENTA analyst upgrades and downgrades
DateFirmActionFromTo
Nov 26, 2024BairdMaintainedOutperformOutperform
Nov 26, 2024JMP SecuritiesReiteratedMarket OutperformMarket Outperform
Oct 10, 2024HC Wainwright & Co.ReiteratedBuyBuy
Oct 9, 2024JMP SecuritiesReiteratedMarket OutperformMarket Outperform
Sep 27, 2024JMP SecuritiesReiteratedMarket OutperformMarket Outperform
Aug 6, 2024JP MorganMaintainedUnderweightUnderweight
Aug 6, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 7, 2024HC Wainwright & Co.MaintainedBuyBuy
May 7, 2024JMP SecuritiesMaintainedMarket OutperformMarket Outperform
Feb 8, 2024JP MorganMaintainedUnderweightUnderweight
Nov 22, 2023OppenheimerMaintainedPerformPerform
Nov 21, 2023HC Wainwright & Co.MaintainedBuyBuy
Nov 21, 2023JMP SecuritiesMaintainedOutperformOutperform
Oct 23, 2023HC Wainwright & Co.MaintainedBuyBuy
Oct 2, 2023RBC CapitalMaintainedSector PerformSector Perform
Sep 19, 2023HC Wainwright & Co.ReiteratedBuyBuy
Aug 9, 2023OppenheimerMaintainedPerformPerform
Aug 8, 2023HC Wainwright & Co.ReiteratedBuyBuy
Aug 8, 2023RBC CapitalReiteratedSector PerformSector Perform
Aug 8, 2023JMP SecuritiesMaintainedMarket OutperformMarket Outperform
Aug 8, 2023JefferiesDowngradeBuyHold
May 11, 2023OppenheimerReiteratedPerformPerform
May 9, 2023RBC CapitalMaintained—Sector Perform
May 9, 2023HC Wainwright & Co.Maintained—Buy
May 9, 2023JMP SecuritiesMaintained—Outperform
Mar 22, 2023RBC CapitalReiterated—Sector Perform
Feb 9, 2023SVB LeerinkReiterated—Market Perform
Feb 8, 2023Piper SandlerMaintained—Overweight
Feb 8, 2023JP MorganMaintained—Neutral
Jan 27, 2023SVB LeerinkMaintained—Market Perform